ClinConnect ClinConnect Logo
Search / Trial NCT04644042

The Effect of Arthroscopic Subacromial Decompression in Patients Who Are Non-responders to Non-operative Treatment.

Launched by HVIDOVRE UNIVERSITY HOSPITAL · Nov 19, 2020

Trial Information

Current as of June 27, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at whether a specific shoulder surgery, called arthroscopic subacromial decompression, is more effective than just a different type of shoulder surgery, known as glenohumeral arthroscopy, for patients who have a condition called subacromial impingement syndrome (SIS) and have not improved with other treatments. SIS often causes shoulder pain and limited movement, and this study aims to find out which approach helps patients feel better after 12 months.

To participate in this trial, patients need to have a confirmed diagnosis of SIS, have experienced shoulder pain for at least six months, and have tried physical therapy without improvement for at least three months. They also need to be considered candidates for surgery by a shoulder specialist. The trial is open to adults aged between 18 and 80, and anyone interested in participating should be able to attend follow-up appointments for rehabilitation. This study is currently recruiting participants, so if you or a loved one are dealing with persistent shoulder pain, this could be an opportunity to explore new treatment options.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • SIS diagnosis (Consultant's clinical diagnosis of SIS + at least 3 out of 5 positive tests from the following: Hawkin's, Neer's, Jobe's, Painful arc and external rotation resistance test)
  • Positive subacromial injection test
  • Insidious onset of shoulder pain
  • Considered a surgical candidate by an orthopedic shoulder specialist.
  • Symptoms for at least 6 months
  • Completion of at least 3 months supervised shoulder training
  • No improvement in symptoms for at least 3 months
  • The patient must be expected to be able to attend rehabilitation and post-examinations.
  • Exclusion Criteria:
  • Terminal illness or severe medical illness (ASA score higher than or equal to 4), systemic musculoskeletal disease, inflammatory joint disease (e.g. rheumatoid arthritis), symptomatic cervical spine pathology or thoracic outlet syndrome.
  • Full-thickness rotator cuff tear, calcified tendonitis, labral tear, frozen shoulder, biceps tendon pathology, acromioclavicular osteoarthrosis, glenohumeral osteoarthrosis or other concomitant shoulder pathology.
  • Previous surgery or radiotherapy on the affected shoulder.
  • Pregnancy
  • Ongoing workers compensation case or job rehabilitation process

About Hvidovre University Hospital

Hvidovre University Hospital is a leading clinical research institution located in Denmark, dedicated to advancing medical science through rigorous clinical trials and innovative healthcare solutions. As a prominent academic hospital, it integrates patient care with research, fostering collaboration among multidisciplinary teams of healthcare professionals, researchers, and academic institutions. Hvidovre University Hospital is committed to enhancing patient outcomes by conducting high-quality clinical studies across various therapeutic areas, ensuring adherence to ethical standards and regulatory compliance. Its state-of-the-art facilities and focus on translational medicine position the hospital as a key player in the development of new treatments and therapies, ultimately contributing to the improvement of public health.

Locations

Hvidovre, , Denmark

Patients applied

0 patients applied

Trial Officials

Kristoffer Barfod, MD

Study Director

Sports Orthopedic Research Center - Copenhagen (SORC-C), Hvidovre Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials